AFFIRM-AHF
#AHA2020
Important trial showing benefit of iron carboxymaltose in acute #heartfailure
Significant 
in HF
It may change guidelines, highlighting the need to study and treat ID in the acute setting
#AHA2020 Important trial showing benefit of iron carboxymaltose in acute #heartfailure
Significant 
in HF
It may change guidelines, highlighting the need to study and treat ID in the acute setting
conclusions (sorry for the typo)...
Read on Twitter